Wnt/β-Catenin in Acute Kidney Injury and Progression to Chronic Kidney Disease.

Semin Nephrol

Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN; Department of Medicine, Veterans Affairs Hospital, Tennessee Valley Healthcare System, Nashville, TN; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN. Electronic address:

Published: March 2020

Acute kidney injury (AKI) portends a poor clinical prognosis and increases the risk for the development of chronic kidney disease (CKD). Currently, there are no therapies to treat AKI or prevent its progression to CKD. Wnt/β-catenin is a critical regulator of kidney development that is up-regulated after injury. Most of the literature support a beneficial role for Wnt/β-catenin in AKI, but suggest that this pathway promotes the progression of tubulointerstitial fibrosis, the hallmark of CKD progression. We review the role of Wnt/β-catenin in renal injury with a focus on its potential as a therapeutic target in AKI and in AKI to CKD transition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172007PMC
http://dx.doi.org/10.1016/j.semnephrol.2020.01.004DOI Listing

Publication Analysis

Top Keywords

acute kidney
8
kidney injury
8
chronic kidney
8
kidney disease
8
role wnt/β-catenin
8
kidney
5
aki
5
wnt/β-catenin
4
wnt/β-catenin acute
4
injury
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!